MHC-HM406-100μg / 询价
MHC-HM406-500μg / 询价
MHC-HM406-500μgx2 / 询价
- 客服电话
- 技术支持
Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein
Recombinant Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein is expressed from HEK293 with His tag and Avi at the C-Terminus.It contains Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide [Accession | P13747(HLA-E*01:03)&P61769(B2M)&VMAPRTLVL].
The protein has a predicted MW of 50.2 kDa. Due to glycosylation, the protein migrates to 52-60 kDa based on Bis-Tris PAGE result.
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Less than 1EU per μg by the LAL method.
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3 months after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer is greater than 95% as determined by SEC-HPLC.
Immobilized Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer, His Tag at 1μg/ml(100μl/well) on the plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.1ng/ml determined by ELISA (QC Test).
HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules performed by cytotoxic lymphocytes.
HLAE; sHLA-E; HLAE; MHC class I antigen E; MHC HLA-E alpha-1; MHC HLA-E alpha-2.1; MHC; QA1
(1)Kanevskiy L, Erokhina S, Kobyzeva P, Streltsova M, Sapozhnikov A, Kovalenko E. Dimorphism of HLA-E and its Disease Association. Int J Mol Sci. 2019 Nov 4;20(21):5496. doi: 10.3390/ijms20215496. PMID: 31690066; PMCID: PMC6862560.
